暢聯股份(603648.SH):嘉融投資完成減持1%股份
格隆匯11月12日丨暢聯股份(603648.SH)公佈,本次減持計劃實施之前,嘉融投資有限公司(以下簡稱“嘉融投資”)持有公司股份1964.83萬股,佔公司總股本的5.33%。上述股份全部為公司首次公開發行股票前已持有的股份,該部分股份已於2018年9月13日解除限售並上市流通。
2019年11月12日,公司收到嘉融投資《關於減持股份結果的告知函》。在本次減持計劃期間,嘉融投資於2019年7月5日至2019年7月26日期間通過集中競價交易方式減持公司股份368.52萬股,佔公司總股本的1.00%。截至2019年11月12日,嘉融投資本次減持計劃時間區間屆滿,本次減持計劃完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.